Company intelligence / Profile preview

CM-CIC Innovation

Paris, France

Ownership: Private
Development stage: Other

Overview

CM-CIC Innovation is a venture capital firm with 92 total investments, including 16 in Health Care and 11 in Biotechnology. It focuses on early-stage ventures, with peak activity in 2023, and has made 18 exits. Notable portfolio companies include Nanobiotix (biotech). Investments typically range from 5-10 million dollars, often co-investing with Bpifrance, CapDecisif, and Omnes Capital.

Industry: Investors

Partnerships

BpifranceCapDecisifOmnes Capital

Beyond the preview

Go deeper on CM-CIC Innovation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CM-CIC Innovation.

Explore the full profile